VTVT — vTv Therapeutics Inc. | XLV Holdings | StockAdder

(VTVT)

vTv Therapeutics Inc.

Live chart and latest VTVT stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

VTVT News

vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts

Apr 15, 2026 Yahoo Finance

vTv Therapeutics (VTVT) Reports $27M 2025 Net Loss Amid Cadisegliatin Advancements

Mar 17, 2026 Stock Titan

New vTv hire gets 4,000 stock options priced at $39.54

Apr 7, 2026 Sahm

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apr 8, 2026 Seeking Alpha

VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst

Feb 28, 2026 The Globe and Mail

Analysts Offer Insights on Healthcare Companies: vTv Therapeutics (VTVT) and Oxford BioMedica (OtherOXBDF)

Mar 12, 2026 Meyka

BTIG Maintains Buy on vTv Therapeutics Inc (VTVT) March 11, 2026

Mar 12, 2026 Yahoo Finance

vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737

Mar 3, 2026 Stock Titan

Millennium Management (NASDAQ: VTVT) reports a 5.0% holding in vTv

Mar 27, 2026 GuruFocus

BTIG Initiates Coverage on vTv Therapeutics (VTVT) with a "Buy" Rating | VTVT Stock News

Nov 19, 2025 MarketBeat

vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Average Rating of "Moderate Buy" from Analysts

Mar 21, 2026 Intellectia AI

VTVT Forecast — Price Prediction for 2026. Should I Buy VTVT?

May 27, 2025 Benzinga

This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Mar 12, 2026 Yahoo Finance

An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here?

Jan 5, 2026 Stock Titan

Biotech developing oral type 1 diabetes drug joins ROTH investor event